Bart De Taeye

Director at Aelin Therapeutics

Bart De Taeye is Investment Manager in the Life Sciences & Care team at PMV. He holds a PharmD and PhD in Pharmaceutical Sciences, has more than 20 years of research experience including 15 years related to drug discovery, and more than 7 years experience with business development and company creation. Bart graduated from the KU Leuven where he also obtained a Postgraduate degree in Business Economics to complement his scientific background. After a postdoc and assistant professorship at Vanderbilt University and Northwestern University, focusing on a better understanding of and the development of novel treatments for the metabolic syndrome, Bart joined reMYND in 2011 as a Project Leader Drug Discovery, to build a diabetes drug discovery platform. Driven by his interest to advance innovative science to applications with societal impact, Bart became a Search and Evaluation Lead at Cistim in 2014, to scout for innovative technologies, while also managing contractual relationships. In 2018, Bart joined VIB as Business Development Manager to support the translation of VIB’s research, where he supported various drug discovery projects, the creation of new VIB spin-off companies and closing of licensing deals.

Timeline

  • Director

    Current role